BIL 06vAlternative Names: BIL-06v
Latest Information Update: 07 Jun 2016
At a glance
- Originator Biosceptre International; Peptech UK
- Developer Biosceptre International
- Class Peptide vaccines
- Mechanism of Action Purinergic P2X7 receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer